Skip to main content
. 2021 Aug 4;14:2977–2989. doi: 10.2147/IDR.S317187

Table 4.

Distributions of HIV-1-Infected MSM with ART Failure Within the Three Major Transmission Networks

Variables CRF01_AE Sequences P For Fisher Exact Tests CRF07_BC Sequences P for Fisher Exact Tests CRF55_01B Sequences P for Fisher Exact Tests
Within Transmission Network, n=27(n/N, %) Total Sequences N=186 Within Transmission Network, n=33(n/N, %) Total Sequences N=84 Within Transmission Network, n= 52(n/N, %) Total Sequences N=84
Age(years)
 15–35 19(15.2) 125 0.929 21(41.2) 51 0.750 29(64.4) 45 0.935
 36–50 7(13.2) 53 10(40.0) 25 21(60.0) 35
 ≥51 1(12.5) 8 2(25.0) 8 2(50.0) 4
Occupation
 Student 1(25.0) 4 0.482 4(66.7) 6 0.319 3(75.0) 4 0.845
 Farmer 2(20.0) 10 2(50.0) 4 2(66.7) 3
 Employed 14(17.5) 80 16(45.7) 35 29(63.0) 46
 Unemployed 4(8.7) 46 6(28.6) 21 12(60.0) 20
 Unknown 6(13.0) 46 5(27.8) 18 6(54.6) 11
Marital status
 Unmarried 20(14.7) 136 0.802 27(45.0) 60 0.112 31(64.6) 48 0.638
 Married or cohabiting 5(12.5) 40 5(22.7) 22 15(53.6) 28
 Divorced or separated 2(20.0) 10 1(50.0) 2 6(75.0) 8
WHO classification
 I 5(17.2) 29 0.604 4(33.3) 12 0.342 10(90.9) 11 0.157
 II 3(17.7) 17 5(27.8) 18 8(53.3) 15
 III 18(15.0) 120 21(42.0) 50 28(56.0) 50
 IV 1(5.0) 20 3(75.0) 4 6(75.0) 8
Geographical region
 Pearl River Delta 24(15.1) 159 0.274 30(40.0) 75 0.392 42(59.2) 71 0.476
 Eastern 0(0.0) 6 0(0.0) 1 3(75.0) 4
 Western 3(27.3) 11 0(0.0) 3 5(83.3) 6
 Northern 0(0.0) 10 3(60.0) 5 2(66.7) 3
Treatment duration(year)
 <1 12(16.4) 73 0.311 4(21.1) 19 0.176 22(57.9) 38 0.693
 1–3 9(11.0) 82 21(41.2) 51 23(62.2) 37
 >3 6(19.4) 31 8(57.1) 14 7(77.8) 9
Baseline CD4+T cell count (cells/mm3)
 ≤200 17(12.8) 133 0.356 9(26.5) 34 0.068 31(59.6) 52 0.500
 >200 10(18.9) 53 24(48.0) 50 21(65.6) 32
Viral load (log10)
 3~ 3(5.9) 51 0.015 15(33.3) 45 0.287 15(60.0) 25 0.662
 4~ 21(21.9) 96 16(50.0) 32 24(66.7) 37
 ≥5 3(7.7) 39 2(28.6) 7 13(56.6) 22
Drug resistance
 Yes 16(12.2) 131 0.178 5(16.7) 30 0.002 37(54.4) 68 0.021
 No 11(20.0) 55 28(51.9) 54 15(93.8) 16